Cluster 507: evaluable measurable disease patients subjects parts radiologically participants phase presence 
Cluster 2138: measurable disease defined following patients imaging non evaluable radiologically irrecist 
Cluster 2374: evaluable disease patients imaging metastatic response phase presence lesion evidence 
